Cargando…
Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus : Protective rEg.P29 epitope against E. granulosus
Echinococcus granulosus causes echinococcosis, an important zoonotic disease worldwide and a major public health issue. Vaccination is an economical and practical approach for controlling E. granulosus. We have previously revealed that a recombinant protein P29 (rEg.P29) is a good vaccine candidate...
Autores principales: | Lv, Yongxue, Zhu, Yazhou, Chang, Liangliang, Yang, Jihui, Zhao, Yinqi, Zhao, Jiaqing, Wang, Yana, Zhu, Mingxing, Wu, Changyou, Zhao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827856/ https://www.ncbi.nlm.nih.gov/pubmed/35607954 http://dx.doi.org/10.3724/abbs.2022036 |
Ejemplares similares
-
Changes in intestinal flora of mice induced by rEg.P29 epitope peptide vaccines
por: Zhang, Tingting, et al.
Publicado: (2023) -
Identification of B‐cell dominant epitopes in the recombinant protein P29 from Echinococcus granulosus
por: Lv, Yongxue, et al.
Publicado: (2022) -
Immunoprotection of recombinant Eg.P29 against Echinococcus granulosus in sheep
por: Wang, Hao, et al.
Publicado: (2016) -
Clinical characteristics and antibodies against Echinococcus granulosus recombinant antigen P29 in patients with cystic echinococcosis in China
por: Tao, Jia, et al.
Publicado: (2022) -
The prediction of T- and B-combined epitope and tertiary structure of the Eg95 antigen of Echinococcus granulosus
por: MA, XIUMIN, et al.
Publicado: (2013)